← All trials
NCT04993872
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 18, 2021
- Primary completion
- Oct 30, 2022
- Completion date
- Oct 30, 2023
- First posted
- Aug 6, 2021
- Last posted
- Aug 6, 2021
- Enrollment
- 20
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'BaLead sponsor
- CHU Henri MondorCollaborator
- CHU Henri MondorCollaborator
- LambertCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.